Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509678 · ClinicalTrials.gov registry record · Phase 1
Rituxan With or Without Methotrexate in Psoriatic Arthritis
A Phase 1 study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00509678: Completed Phase 1 study, sponsored by Swedish Medical Center.
NCT00509678 is a Phase 1 study that has completed, run by Swedish Medical Center. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00509678, a Phase 1 study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.
Interventions
- DRUG Rituximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
What the finished NCT00509678 record still lists
NCT00509678 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Rituximab is the first listed.
NCT00509678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00509678 about?
NCT00509678 is a clinical study titled "Rituxan With or Without Methotrexate in Psoriatic Arthritis". The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.
What is the current status of trial NCT00509678?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2006-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00509678?
The interventions under investigation include: Rituximab (DRUG).
Who is sponsoring clinical trial NCT00509678?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00509678's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia